Back to VKTX Stock Lookup

Viking Therapeutics (VKTX) – Hot FDA News

Apr 11, 2019 07:03 AM Viking Therapeutics (VKTX) Presents New Data from Phase 2 Study of VK2809 in Patients with NAFLD and Elevated LDL-Cholesterol at EASL
Sep 18, 2018 07:08 AM Viking Therapeutics (VKTX) Says Phase 2 Study of VK2809 in Patients with NAFLD and Elevated LDL-Cholesterol Achieved its Primary Endpoint
Nov 28, 2017 07:05 AM
Oct 24, 2017 07:07 AM
Oct 23, 2017 07:08 AM

Back to VKTX Stock Lookup